Opportunity
Federal Register #2026-05848
USITC Regulatory Reviews: Citric Acid, Erythritol, and Hydrodermabrasion Systems from China
Buyer
INTERNATIONAL TRADE COMMISSION, UNITED STATES
Posted
March 26, 2026
Respond By
April 28, 2026
Identifier
2026-05848
NAICS
926150
This opportunity involves regulatory reviews and investigations conducted by the U.S. International Trade Commission (USITC) regarding imports from China: - Government Buyer: - U.S. International Trade Commission (USITC), Office of the Secretary - OEMs and Vendors: - No OEMs or vendors are being solicited; this is not a procurement of goods or services - Products/Services Reviewed: - Erythritol from China (HTSUS 2905.49.40) - Determined to be subsidized and sold at less than fair value, causing material injury to U.S. industry - Citric Acid and Certain Citrate Salts from China - Subject to expedited five-year reviews to assess likelihood of injury continuation or recurrence if antidumping and countervailing duty orders are revoked - Certain Hydrodermabrasion Systems and Components - Found to violate Section 337; limited exclusion and cease and desist orders issued but suspended due to patent expiration - Unique/Notable Requirements: - The process is a regulatory review, not a procurement - Involves written submissions and comments from interested parties - Focuses on compliance with Commission rules and procedures - Reviews are conducted at the USITC's federal facility in Washington, DC - No specific products, part numbers, or purchase quantities are being requested - Locations: - Primary place of performance and government facility: U.S. International Trade Commission, 500 E Street SW, Washington, DC 20436 - Other referenced locations (not for performance): HydraFacial LLC (Long Beach, CA), Cartessa Aesthetics, LLC (Melville, NY)
Description
The U.S. International Trade Commission has scheduled expedited five-year reviews under the Tariff Act of 1930 to determine whether revocation of antidumping and countervailing duty orders on citric acid and certain citrate salts from China would likely lead to continuation or recurrence of material injury. The reviews were initiated following an adequate domestic interested party response and an inadequate respondent party response. The Commission will conduct expedited reviews and has set deadlines for written comments and submissions related to the reviews.